US Launches Trade Investigation Into Germany Over Drug Pricing

U.S. Trade Representative ⁠Jamieson Greer said that Germany reducing its spending on pharmaceuticals ‘is a serious step backwards.’

U.S. Trade Rep. Jamieson Greer speaks at the National Conservative Convention in Washington, on Sept. 3, 2025. Dominic Gwinn / Middle East Images via AFP via Getty Images

The United States has launched a ‌trade investigation into a German plan to lower its spending on pharmaceutical products, U.S. Trade Representative ⁠Jamieson Greer said on Thursday.

The United States claims that there is evidence that “Germany implements unfair pricing policies and practices with regard to innovative pharmaceutical products,” according to the Office of the Trade Representative.